Partners Gp Viii, L.L.C.Pol... Net Worth

The estimated Net Worth of Partners Gp Viii, L.L.C.Pol... is at least $6.64 Million dollars as of 21 July 2020. Partners Pol owns over 36,111 units of Pandion Therapeutics stock worth over $6,642,791 and over the last 4 years Partners sold PAND stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Partners Pol PAND stock SEC Form 4 insiders trading

Partners has made over 1 trades of the Pandion Therapeutics stock since 2020, according to the Form 4 filled with the SEC. Most recently Partners bought 36,111 units of PAND stock worth $649,998 on 21 July 2020.

The largest trade Partners's ever made was buying 36,111 units of Pandion Therapeutics stock on 21 July 2020 worth over $649,998. On average, Partners trades about 36,111 units every 0 days since 2020. As of 21 July 2020 Partners still owns at least 110,621 units of Pandion Therapeutics stock.

You can see the complete history of Partners Pol stock trades at the bottom of the page.

Insiders trading at Pandion Therapeutics

Over the last 4 years, insiders at Pandion Therapeutics have traded over $0 worth of Pandion Therapeutics stock and bought 1,743,632 units worth $30,815,954 . The most active insiders traders include Plc Gsk, Capital Management, L.P.Kol... und Daniel J. Becker. On average, Pandion Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $9,518,646. The most recent stock trade was executed by Daniel J. Becker on 19 November 2020, trading 197,716 units of PAND stock currently worth $2,989,466.

What does Pandion Therapeutics do?

Complete history of Partners Pol stock trades at Pandion Therapeutics

Pandion Therapeutics executives and stock owners

Pandion Therapeutics executives and other stock owners filed with the SEC include:

• Capital Management, L.P.Kol...,
  
• Nancy Stagliano,
  Director
• Vikas Goyal,
  See Remarks
• Joanne L. Viney,
  See Remarks
• Partners Gp Viii, L.L.C.Pol...,
  
• Rizzuto Carlo,
  Director
• Jill Carroll,
  Director
• Katina Dorton,
  Director
• Donald Frail,
  Director
• Christopher Fuglesang,
  Director
• Gregg Beloff,
  See Remarks
• Alan L Crane,
  Director
• Mitchell Mutz,
  Director
• Eric D Larson,
  Vice President, Finance
• Daniel J. Becker,
  Director
• Rahul Kakkar,
  Chief Executive Officer
• Plc Gsk,
  Director
• John Sundy,
  Chief Medical Officer
• Edward D. Freedman,
  Chief Operating Officer